Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$673,776,592
-$87,290,360 QoQ
Shares Held
732,549
+3.4% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
1.76%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 77.07498064975859.ToString("F0")%
Shared 8.105123343284886.ToString("F0")%
None 14.819896006956531.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2026CallValue
$275,931
CallShares
300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Cerity Partners LLC holds $2,080,837,635 across 16 Drug Manufacturers - General names. LLY ranks #1 (32.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
732,549 | $673,776,592 | |
| 2 | JNJ |
Johnson & Johnson
|
1,846,524 | $451,364,326 | |
| 3 | ABBV |
AbbVie Inc.
|
1,215,422 | $264,342,129 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,639,510 | $197,216,656 | |
| 5 | AMGN |
Amgen Inc
|
433,555 | $152,546,325 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,392,773 | $84,471,681 | |
| 7 | AZN |
Astrazeneca PLC
|
301,215 | $59,405,621 | |
| 8 | NVS |
Novartis AG
|
329,910 | $50,393,751 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $275,931 | 300 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $673,776,592 | 732,549 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $761,066,952 | 708,180 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $526,914,829 | 690,583 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $473,329,056 | 607,198 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $495,653,368 | 600,130 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $448,389,180 | 580,815 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $514,305,888 | 580,520 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $480,239,808 | 530,429 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $425,754,169 | 547,270 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $339,703,042 | 582,761 | Shares | Other | 2024-01-26 | |
| 2023-09-30 | $122,042,918 | 227,213 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $121,688,585 | 259,475 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $80,495,930 | 234,395 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $82,091,569 | 224,392 | Shares | Other | 2023-02-15 | |
| 2022-09-30 | $63,035,142 | 194,944 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $62,007,366 | 191,245 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $8,343,389 | 29,135 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $6,354,441 | 23,005 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,575,745 | 11,148 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $2,562,820 | 11,166 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $2,144,880 | 11,481 | Shares | Sole | 2021-08-11 | |
| 2020-12-31 | $2,284,574 | 13,531 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,769,135 | 11,952 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,312,783 | 7,996 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,053,994 | 7,598 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||